13D Filing: Biotechnology Value Fund LP and BioLineRX Ltd. (BLRX)

Page 2 of 15

Page 2 of 15 – SEC Filing

1 NAME OF REPORTING PERSON
BIOTECHNOLOGY VALUE FUND, L.P.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒
(b) ☐
3 SEC USE ONLY
4 SOURCE OF FUNDS
WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY – 0 –
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 12,129,350*
PERSON WITH 9 SOLE DISPOSITIVE POWER
– 0 –
10 SHARED DISPOSITIVE POWER
12,129,350*
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,129,350*
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.7%
14 TYPE OF REPORTING PERSON
PN

____________________

* Represents 12,129,350
American Depositary Shares (“ADS”) (each ADS represents one Share (as defined below)). Includes 30,625 ADSs
issuable upon the exercise of certain Series A Warrants (as defined below) to purchase ADSs.

2

Follow Biolinerx Ltd. (NASDAQ:BLRX)

Page 2 of 15